首页> 外文期刊>Journal of Periodontology >Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives.
【24h】

Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives.

机译:强力霉素和非抗菌化学修饰的四环素衍生物对牙周病原菌的蛋白水解,丝氨酸蛋白酶降解和明胶酶b激活活性的抑制。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Tetracyclines, particularly doxycycline (Doxy), and their non-antimicrobial chemically-modified derivatives (CMTs) inhibit the activities of human matrix metalloproteinases (MMPs), and reduce the severity and progression of periodontal disease in animal models and humans. In this study, the effects of Doxy and CMT-1, -3, and -5 on proteolytic, serpinolytic, and progelatinase-B activation activities of potent periodontopathogens were studied. METHODS: The effect of Doxy and CMTs (0.5 to 50 microM) on proteolytic activities were investigated by incubating bacteria with chromogenic substrates or human serum albumin. A collagenolytic fraction of Porphyromonas gingivalis was used to evaluate the effect of these substances on collagenolytic (type I collagen) and serpinolytic (alpha1-proteinase inhibitor) activities. Lastly, the effect of Doxy on progelatinase-B (pro-MMP-9) activation by purified proteinases from P. gingivalis and Treponema denticola was investigated by SDS-PAGE/Western immunoblotting. RESULTS: Doxy and CMTs, except CMT-5 which lacks the structural elements required for cation chelation, inhibited Arg- and Lys-gingipain activities as well as collagenolytic activity of P. gingivalis. Doxy and CMTs did not markedly affect the chymotrypsin-like activity of T. denticola but inhibited its trypsin-like activity. In addition, degradation of human serum albumin by cells of P. gingivalis and T. denticola was strongly inhibited by Doxy and CMT-1. Doxy and CMT-1 also inhibited the inactivation of alpha1-proteinase inhibitor (serpinolytic activity) by a collagenolytic fraction of P. gingivalis. Lastly, Doxy prevented the latent to active conversion of human neutrophil progelatinase-B (pro-MMP-9) by Arg-gingipains A/B of P. gingivalis but not by the chymotrypsin-like proteinase of T. denticola. CONCLUSIONS: Data from this study suggest that Doxy and CMTs have the potential to inhibit the periodontopathogenic bacterial proteinases, which contribute to tissue destruction cascades during periodontitis directly and indirectly by triggering the host response.
机译:背景:四环素,特别是强力霉素(Doxy)及其非抗菌化学修饰衍生物(CMT)抑制人类基质金属蛋白酶(MMP)的活性,并降低动物模型和人类牙周疾病的严重性和进展。在这项研究中,研究了强力牙周病原菌的Doxy和CMT-1,-3和-5对蛋白水解,丝氨酸溶解和明胶酶B活化活性的影响。方法:通过将细菌与生色底物或人血清白蛋白一起孵育,研究了Doxy和CMT(0.5至50 microM)对蛋白水解活性的影响。牙龈卟啉单胞菌的胶原蛋白溶解级分用于评估这些物质对胶原蛋白水解(I型胶原蛋白)和血清丝蛋白溶解(α1-蛋白酶抑制剂)活性的影响。最后,通过SDS-PAGE / Western免疫印迹法研究了Doxy对来自牙龈卟啉单胞菌和密螺旋体的纯化蛋白酶对明胶酶-B(pro-MMP-9)活化的影响。结果:除CMT-5缺乏阳离子螯合所需的结构元素外,Doxy和CMTs抑制了牙龈卟啉单胞菌的Arg和Lys-gingipain活性以及胶原蛋白水解活性。 Doxy和CMT并没有显着影响T. denticola的胰凝乳蛋白酶样活性,但抑制了其胰蛋白酶样活性。此外,Doxy和CMT-1强烈抑制了牙龈卟啉单胞菌和树突触杆菌的细胞降解人血清白蛋白。 Doxy和CMT-1还通过牙龈卟啉单胞菌的胶原蛋白分解部分抑制了α1-蛋白酶抑制剂的失活(丝氨酸分解活性)。最后,Doxy阻止了牙龈卟啉单胞菌的Arg-gingipains A / B潜在地主动转化人嗜中性粒细胞的明胶酶B(pro-MMP-9),但不能阻止T. denticola的胰凝乳蛋白酶样蛋白酶。结论:这项研究的数据表明,Doxy和CMTs具有抑制牙周病原性细菌蛋白酶的潜能,它们可通过触发宿主反应而直接或间接地导致牙周炎期间的组织破坏级联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号